Enoxaparin for Symptomatic COVID-19 Managed in the Ambulatory Setting: an Individual Patient Level Analysis of the OVID and ETHIC Trials.
Stefano Barco,Saverio Virdone,Andrea Gotschi,Walter Ageno,Juan I. Arcelus,Roland Bingisser,Giuseppe Colucci,Frank Cools,Daniel Duerschmied,Harry Gibbs,Riccardo M. Fumagalli,Bernhard Gerber,Sylvia Haas,Jelle C. L. Himmelreich,Richard Hobbs,Lukas Hobohm,Barry Jacobson,Gloria Kayani,Renato D. Lopes,Peter Maccallum,Evy Micieli,Marc Righini,Helia Robert-Ebadi,Ana Thereza Rocha,Thomas Rosemann,Jitendra Sawhney,Sebastian Schellong,Tim Sebastian,David Spirk,Stefan Stortecky,Alexander G. G. Turpie,Davide Voci,Nils Kucher,Karen Pieper,Ulrike Held,Ajay K. Kakkar THROMBOSIS RESEARCH（2023）
Key words
COVID-19,Anticoagulation,Venous thromboembolism,Trial,Death
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper